Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 12.2.2021GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)27340Panadol Ultra Rapide (tbl eff 24 (strip lam.))22.2.2021R
 12.2.2021GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)3489DVoltaren Forte 2,32 % gél (gel 1x180 g (tuba LDPE/Al/LLDPE/HDPE/Antiblock Masterbatch s odkláp.uzáver.))22.2.2021R
 12.2.2021GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)3489DVoltaren Forte 2,32 % gél (gel 1x180 g (tuba LDPE/Al/LLDPE/HDPE/Antiblock Masterbatch s odkláp.uzáver.))15.2.2021R
 12.2.2021Takeda Manufacturing Austria AG (TKM-5)97248KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml/10 g (liek.inj.skl.))12.2.2021R
 12.2.2021Fresenius Kabi Deutschland GmbH (FRK-1)42741Propofol MCT/LCT Fresenius 10 mg/ml injekčná/infúzna emulzia (emu ijf 10x50 ml (liek.inj.skl.))12.2.2021R
 12.2.2021Fresenius Kabi Deutschland GmbH (FRK-1)42747Propofol MCT/LCT Fresenius 20 mg/ml injekčná/infúzna emulzia (emu ijf 10x50 ml (liek.inj.skl.))12.2.2021R
 12.2.2021G.L. Pharma GmbH (GLH-2)2753DAglandin 0,5 mg/0,4 mg tvrdé kapsuly (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))11.2.2021O
 11.2.2021Mylan Ireland Limited (MNY)80861Escitalopram Mylan 10 mg (tbl flm 28x10 mg (blis.PVC/PVDC/Al))12.2.2021R
 11.2.2021AS KALCEKS (AKA)9318CMidazolam Kalceks 5 mg/ml injekčný/infúzny roztok (sol ijf 10x1 ml (amp.skl.))11.2.2021R
 11.2.2021Berlin-Chemie AG (BCE)46963L-Thyroxin 75 Berlin-Chemie (tbl 100)9.2.2021R
 11.2.2021Gedeon Richter Plc. (GDN)31251VINCRISTIN LIQUID-RICHTER 1 mg (sol inj 5x1 ml/1 mg (liek.inj.skl.))15.5.2021Z
 11.2.2021Gedeon Richter Plc. (GDN)86922Ossica 150 mg filmom obalené tablety (tbl flm 3x150 mg (blis.PVC/PE/PVDC/Al))11.2.2021O
 11.2.2021KRKA, d.d., Novo mesto (KRK-2)1247CDexametazón Krka 4 mg tablety (tbl 20x4 mg (blis.OPA/Al/PVC/Al))15.2.2021O
 11.2.2021KRKA, d.d., Novo mesto (KRK-2)1275CDexametazón Krka 20 mg tablety (tbl 20x20 mg (blis.OPA/Al/PVC/Al))1.3.2021R
 11.2.2021KRKA, d.d., Novo mesto (KRK-2)1949CLinezolid Krka 2 mg/ml infúzny roztok (sol inf 1x300 ml (vak polyolefínový))1.3.2021R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)